Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

(Reuters) - Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival ...

Researchers saw significant increases in testosterone levels for men with obesity or Type 2 diabetes while taking GLP-1 medications, The Hill wrote. Also in the news: vaping, PFAS, junk food, and more ...

GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite ...

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.

Supplements were also to blame when a 53-year-old woman’s left hand suddenly went numb, according to a case study in the ...

FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some ...

Singer songwriter Justin Timberlake is the latest in a string of famous faces to say they have been struck by tick-borne Lyme disease.